CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
Authors
Keywords
-
Journal
Frontiers of Medicine
Volume 16, Issue 3, Pages 322-338
Publisher
Springer Science and Business Media LLC
Online
2022-06-10
DOI
10.1007/s11684-021-0901-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling
- (2021) Elisa Landoni et al. Cancer Immunology Research
- In like a lamb; out like a lion: Marching CAR-T cells towards enhanced efficacy in ALL
- (2021) Pouya Safarzadeh Kozani et al. MOLECULAR CANCER THERAPEUTICS
- Context matters in CAR T cell tonic signaling
- (2021) Kristen Hege NATURE MEDICINE
- Strategies for Dodging the Obstacles in CAR T Cell Therapy
- (2021) Pooria Safarzadeh Kozani et al. Frontiers in Oncology
- Novel antigens of CAR T cell therapy: New roads; old destination
- (2021) Pooria Safarzadeh Kozani et al. Translational Oncology
- Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
- (2020) Hanren Dai et al. Journal of Hematology & Oncology
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
- (2020) Emmanuel Donnadieu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia
- (2020) Mohadese Hashem Boroojerdi et al. MEDICAL ONCOLOGY
- Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
- (2020) Ru Zhou et al. Frontiers in Immunology
- CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARs
- (2019) F. Rahbarizadeh et al. ADVANCED DRUG DELIVERY REVIEWS
- Modulation of Target Antigen Density Improves CAR T Cell Functionality and Persistence
- (2019) Sneha Ramakrishna et al. CLINICAL CANCER RESEARCH
- CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
- (2019) Ru Zhou et al. Frontiers in Immunology
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
- (2019) Zi Mei et al. Cancer Medicine
- Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004
- (2018) Shu-ta Wu et al. PLoS One
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Strategies to Address Chimeric Antigen Receptor Tonic Signaling
- (2018) Adam Ajina et al. MOLECULAR CANCER THERAPEUTICS
- Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells
- (2018) John P. Murad et al. Frontiers in Immunology
- FDA Approves Second CAR T-cell Therapy
- (2017) Cancer Discovery
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- The Cosmc connection to the Tn antigen in cancer
- (2017) Tongzhong Ju et al. Cancer Biomarkers
- Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model
- (2016) Shinji Abe et al. CANCER SCIENCE
- Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells
- (2016) John Maher et al. IMMUNITY
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
- (2016) Fengtao You et al. Science China-Life Sciences
- Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors
- (2016) Laura Jeffords Moore et al. Translational Oncology
- Generation of a monoclonal antibody recognizing the CEACAM glycan structure and inhibiting adhesion using cancer tissue-originated spheroid as an antigen
- (2016) Yumi Sato et al. Scientific Reports
- CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains
- (2016) S. Shiina et al. Cancer Immunology Research
- Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen
- (2016) C. Fu et al. HLA
- Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer
- (2015) Eva Myriokefalitaki et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- What controls the expression of the core-1 (Thomsen—Friedenreich) glycotope on tumor cells?
- (2015) U. Karsten et al. BIOCHEMISTRY-MOSCOW
- Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL
- (2015) Yvette van Kooyk et al. IMMUNOBIOLOGY
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Dynamic interplay between catalytic and lectin domains of GalNAc-transferases modulates protein O-glycosylation
- (2015) Erandi Lira-Navarrete et al. Nature Communications
- The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL
- (2015) Richard Beatson et al. PLoS One
- Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma
- (2015) Teresita N. J. Flores-Téllez et al. PLoS One
- RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells
- (2014) Fumito Tamura et al. Gastric Cancer
- Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma
- (2014) CHENG-WEI LIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor
- (2014) S. Wilkie et al. JOURNAL OF IMMUNOLOGY
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
- (2014) Yukinari Kato et al. Scientific Reports
- T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy
- (2013) Fatemeh Rahimi Jamnani et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- A Single Peptide-Major Histocompatibility Complex Ligand Triggers Digital Cytokine Secretion in CD4+ T Cells
- (2013) Jun Huang et al. IMMUNITY
- Human T Cell Activation Results in Extracellular Signal-regulated Kinase (ERK)-Calcineurin-dependent Exposure of Tn Antigen on the Cell Surface and Binding of the Macrophage Galactose-type Lectin (MGL)
- (2013) Sandra J. van Vliet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer
- (2013) Jennifer M. Curry et al. JOURNAL OF SURGICAL ONCOLOGY
- Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents
- (2012) Zahra Sharifzadeh et al. CANCER LETTERS
- Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity
- (2012) Kirstine Lavrsen et al. GLYCOCONJUGATE JOURNAL
- Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer
- (2012) Kaoru Akita et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cells
- (2012) Sepideh Khaleghi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Knockdown of Core 1 Beta 1, 3-galactosyltransferase Prolongs Skin Allograft Survival with Induction of Galectin-1 Secretion and Suppression of CD8+T Cells
- (2012) Hai-Dan Chen et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
- (2011) A Larsson et al. BRITISH JOURNAL OF CANCER
- Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by PhiC31 integrase
- (2011) Farnoush Jafari Iri-Sofla et al. EXPERIMENTAL CELL RESEARCH
- Mass Spectrometry-Based Identification Of The Tumor Antigen UN1 as the Transmembrane CD43 Sialoglycoprotein
- (2011) Annamaria de Laurentiis et al. MOLECULAR & CELLULAR PROTEOMICS
- A Novel Anti-CEACAM5 Monoclonal Antibody, CC4, Suppresses Colorectal Tumor Growth and Enhances NK Cells-Mediated Tumor Immunity
- (2011) Chaogu Zheng et al. PLoS One
- Structural Basis for Distinct Binding Properties of the Human Galectins to Thomsen-Friedenreich Antigen
- (2011) Cheng-Feng Bian et al. PLoS One
- Seromic profiling of colorectal cancer patients with novel glycopeptide microarray
- (2010) Johannes W. Pedersen et al. INTERNATIONAL JOURNAL OF CANCER
- Stabilization of the Single-Chain Fragment Variable by an Interdomain Disulfide Bond and Its Effect on Antibody Affinity
- (2010) Jian-Xin Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GolgiN-Glycosyltransferases Form Both Homo- and Heterodimeric Enzyme Complexes in Live Cells
- (2010) Antti Hassinen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation ofO-glycosylation through Golgi-to-ER relocation of initiation enzymes
- (2010) David J. Gill et al. JOURNAL OF CELL BIOLOGY
- TCR–peptide–MHC interactions in situ show accelerated kinetics and increased affinity
- (2010) Johannes B. Huppa et al. NATURE
- Down-regulation of core 1 1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1
- (2010) K. Yamada et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Anti-MUC1 Nanobody Can Redirect T-Body Cytotoxic Effector Function
- (2009) Seyed Hamid Aghaee Bakhtiari et al. HYBRIDOMA
- Elevated Golgi pH impairs terminalN-glycosylation by inducing mislocalization of Golgi glycosyltransferases
- (2009) Antti Rivinoja et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Podocalyxin expression in malignant astrocytic tumors
- (2008) Norihito Hayatsu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
- (2008) T. Ju et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now